Dispatch Bio

Raised $216M in a Series A round, announced 23 July 2025.

Total raised: $216M

Latest round Series ACountry United StatesSector Health

Round

$216MSeries A, 23 July 2025

Funds development toward clinical trials expected in 2026.

Amount: $216M
Stage: Series A
Announced: 23 July 2025
Lead: ARCH Venture Partners
Other investors: Parker Institute for Cancer Immunotherapy, Bristol Myers Squibb, Alexandria Venture Investments
Use of funds: Funds development toward clinical trials expected in 2026.
Checked: Amount and date matched across 2 press sources
Sources: Dispatch Bio raises $216M (date approx) biospace.com
Dispatch Bio raises $216M (date approx) pulse2.com

Company

Develops universal CAR T immunotherapy for solid tumors

Based in: Philadelphia, United States
Sector: Health

Questions

How much has Dispatch Bio raised?

Dispatch Bio raised $216M in a Series A round, announced on 23 July 2025.

Who invested in Dispatch Bio?

ARCH Venture Partners led. Investors include ARCH Venture Partners, Parker Institute for Cancer Immunotherapy, Bristol Myers Squibb and Alexandria Venture Investments.